Eton Pharmaceuticals, Inc. (ETON) vs Prestige Consumer Healthcare Inc. (PBH)
Eton Pharmaceuticals, Inc. and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Prestige Consumer Healthcare Inc. is the larger, with a market value of $2.2B against $1.7B — 1.3× the size. Prestige Consumer Healthcare Inc. trades at the lower P/E: 13.0× against 123×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs 12.0%) and the lower return on invested capital (4.70% vs 21.4%). Across the 21 metrics below, Prestige Consumer Healthcare Inc. leads on 13 and Eton Pharmaceuticals, Inc. on 8.
Valuation
Profitability
| Metric | ETON | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 57.87% | 53.53% | 53.94% |
| Operating margin | 15.44% | 26.26% | 0.00% |
| Net margin | 12.02% | 15.57% | 0.00% |
| Free cash flow margin | (7.94%) | 21.30% | 0.00% |
| Return on equity | 35.97% | 9.12% | (0.40%) |
| Return on assets | 11.67% | 4.30% | (3.32%) |
| Return on invested capital | 21.39% | 4.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack